FIELD: chemistry; obtaining of medicinal preparations.
SUBSTANCE: description is given of a compound with general formula where R1 represents a halogen, C1-C6alkyl, CF3, CF2H or cyano, R2 represents C1-C6alkyl, R3 represents 5- or 6 - member hetero-aryl, optionally substituted with one, two or three substitutes, chosen from a group, consisting of a halogen, C1-C6alkyl, C3-C6cycloalkyl, C1-C6alkylhalogen, C1-C6alkoxy, NR'R", or substituted with a 1-morpholinyl group or substituted with thiomorpholinyl groups, 1-oxothiomorpholinyl or 1,1-dioxothiomorpholinyl; R', R" independently represent hydrogen, C1-C6alkyl, (CH2)0,1-(C3-C6)cycloalkyl, R represents hydrogen as well as its pharmaceutical salts and the method of obtaining them. The invention also relates to use of the given amidazole derivatives for obtaining medicinal preparations and to medicinal preparations containing them, meant for prevention or treatment of damages, through the mGluR5 receptor, such as acute and/or chronic neurologic damages, primarily shock pain, or for treatment of chronic and sharp pain.
EFFECT: obtaining of new compounds, with useful biological properties.
40 ex
Title | Year | Author | Number |
---|---|---|---|
IMIDAZOL DERIVATIVES, METHOD OF THEIR OBTAINING AND THEIR APPLICATION, MEDICATION | 2004 |
|
RU2345074C2 |
PHENYLETHENYL- OR PHENYLETHYNYL-DERIVATIVES AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2001 |
|
RU2284323C9 |
NEW DERIVATIVES OF AMINOPYRIDINE AS ANTAGONISTS mGIuR5 | 2004 |
|
RU2330020C2 |
IMIDAZOLE DERIVATIVES AS mGluR5 ANTAGONISTS | 2010 |
|
RU2527106C2 |
IMIDAZOLE III DERIVATIVES | 2004 |
|
RU2360911C2 |
NEW ISOXAZOLIL ETHER DERIVATIVES AS PAM GABA A ALFA5 | 2019 |
|
RU2800160C2 |
INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES | 2014 |
|
RU2666532C2 |
PYRIDINONE AND PYRIDAZINONE DERIVATIVES | 2012 |
|
RU2632915C2 |
BENZOTHIAZOLE DERIVATIVES | 2001 |
|
RU2251419C2 |
ETHYNYL DERIVATIVES | 2016 |
|
RU2722014C2 |
Authors
Dates
2008-06-27—Published
2004-06-07—Filed